NCT00898963View on ClinicalTrials.gov

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

CompletedOBSERVATIONAL
Enrollment

175

Participants

Timeline

Start Date

April 18, 2007

Primary Completion Date

February 11, 2011

Study Completion Date

February 11, 2011

Conditions
Lymphoma
Interventions
GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

polymorphism analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

OTHER

immunologic technique

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT00898963 - Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496 | Biotech Hunter | Biotech Hunter